by PKD Foundation Staff | May 8, 2018 | Research
Our very own Dr. David Baron shares his personal background with PKD, his journey joining the Foundation and his thoughts on the exciting news about the new treatment for ADPKD: Little did I know when I was studying the effects of vasopressin and its modulators...
by PKD Foundation Staff | Apr 30, 2018 | Education, Q and A, Transplantation
We’re ending on a high note as Donate Life Month draws to a close: our very own Senior Director of Community Fundraising, Sue Full, has been approved as a transplant match for best friend and Director of Community Engagement, Nicole Harr! Check out the video...
by PKD Foundation Staff | Apr 25, 2018 | ADPKD, Research
In light of our exciting news about tolvaptan receiving FDA approval as the first ADPKD treatment, we reached out to Benjamin Cowley Jr., M.D. to explain how we reached this amazing milestone. Dr. Cowley was on the Independent Data Monitoring Committee for the...
by PKD Foundation Staff | Apr 24, 2018 | ADPKD, PKD Foundation News, Research
Today is a historic day in providing hope to patients with polycystic kidney disease. We are excited to announce that the U.S. Food and Drug Administration (FDA) granted approval of JYNARQUE™ (tolvaptan) to be the first treatment in the United States for adult...
by PKD Foundation Staff | Apr 18, 2018 | Transplantation
When managing a chronic disease, like PKD, it is important to be your own best advocate. When preparing for a kidney transplant, being your own best advocate is critical to ensure your best outcome. Having been through the transplant evaluation process, here are the...
